Lv11
50 积分 2024-03-02 加入
Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
2小时前
已完结
Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma
2小时前
已完结
Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos
8个月前
已完结
皖公网安备34019202002308
